Tudor Investment Corp ET AL Purchases New Stake in Sabra Healthcare REIT, Inc. $SBRA

Tudor Investment Corp ET AL acquired a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 406,413 shares of the real estate investment trust’s stock, valued at approximately $7,576,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Swiss Life Asset Management Ltd acquired a new position in Sabra Healthcare REIT during the 3rd quarter valued at about $208,000. Cambria Investment Management L.P. grew its position in shares of Sabra Healthcare REIT by 15.6% during the 3rd quarter. Cambria Investment Management L.P. now owns 32,219 shares of the real estate investment trust’s stock worth $601,000 after buying an additional 4,350 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Sabra Healthcare REIT by 33.7% during the third quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock worth $66,904,000 after buying an additional 903,841 shares during the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of Sabra Healthcare REIT during the third quarter worth approximately $1,647,000. Finally, Coldstream Capital Management Inc. acquired a new position in Sabra Healthcare REIT in the third quarter valued at approximately $213,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Stock Up 0.5%

NASDAQ:SBRA opened at $19.69 on Tuesday. Sabra Healthcare REIT, Inc. has a 1 year low of $15.75 and a 1 year high of $21.07. The stock has a 50-day moving average price of $19.76 and a two-hundred day moving average price of $19.06. The stock has a market cap of $4.96 billion, a price-to-earnings ratio of 30.77, a PEG ratio of 1.56 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same quarter in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Analyst Ratings Changes

Several research analysts have recently issued reports on SBRA shares. Citigroup raised their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Cantor Fitzgerald raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, February 17th. Weiss Ratings upgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. Wells Fargo & Company upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Finally, Scotiabank boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a report on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $21.90.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.